Skip to main content
Top
Published in: Malaria Journal 1/2014

Open Access 01-12-2014 | Research

Intermittent use of sulphadoxine-pyrimethamine for malaria prevention: a cross-sectional study of knowledge and practices among Ugandan women attending an urban antenatal clinic

Authors: Charles O Odongo, Ronald K Bisaso, Josaphat Byamugisha, Celestino Obua

Published in: Malaria Journal | Issue 1/2014

Login to get access

Abstract

Background

The WHO recommends supervised administration of sulphadoxine-pyrimethamine (SP) as intermittent preventive treatment for malaria (IPTp) during pregnancy. Logistical constraints have however favoured unsupervised intake of SP-IPTp, casting doubts whether recent guidelines requiring more frequent intake can be effectively implemented. To propose strategies for enhancing compliance under limited supervision, this study sought to identify pregnant women’s knowledge and practices gaps as well as determine predictors of compliance with SP-IPTp, given under limited supervision.

Methods

A cross-sectional study of 700 women used exit interviews at an urban clinic in Uganda to obtain a descriptive summary of demographic and obstetric characteristics, including knowledge, practice and experiences with SP. Predictors of compliance with SP intake instructions were explored using logistic regression.

Results

Median age of respondents was 25 (IQR 22–28) and median parity was two (IQR one to three) while median number of antenatal clinic (ANC) visits was 3.0 (IQR three to four). Most women had completed primary (36%) or ordinary secondary education (25.6%) while 16.1% had not completed primary education. Awareness about SP was high (99.4%) although correct knowledge regarding its use in pregnancy was low (57%), with 15.4% thinking it was used to treat malaria and 26.7% lacking any idea about its use. Correct knowledge on SP use during pregnancy significantly predicted compliance with SP-IPTp instructions (OR 1.98, C.I. 1.12-3.55), while age, education level, parity, number of ANC visits, or history of unwanted effects with SP did not. SP was mostly accessed from hospitals (64.4%) followed by private clinics (16.9%) both for preventive and treatment purposes. SP was considered safe by most women, who were willing to take it again in future, without supervision.

Conclusion

Despite high awareness, knowledge of SP as an intervention for malaria prevention in pregnancy was low. Correct knowledge on use of SP predicted compliance with SP-IPTp intake instructions. Focused malaria-related education during ANC visits may improve compliance with SP intake amidst limited supervision.
Appendix
Available only for authorised users
Literature
1.
go back to reference WHO: World Malaria Report 2012. 2013, Geneva, Switzerland: World Health Organization WHO: World Malaria Report 2012. 2013, Geneva, Switzerland: World Health Organization
3.
go back to reference WHO: A Strategic Framework for Malaria Prevention and Control During Pregnancy in the African Region. 2004, Brazaville: HO Regional Office for Africa WHO: A Strategic Framework for Malaria Prevention and Control During Pregnancy in the African Region. 2004, Brazaville: HO Regional Office for Africa
4.
go back to reference Chico RM, Chandramohan D: Intermittent preventive treatment of malaria in pregnancy: at the crossroads of public health policy. Trop Med Int Health. 2011, 16: 774-785. 10.1111/j.1365-3156.2011.02765.x.CrossRefPubMed Chico RM, Chandramohan D: Intermittent preventive treatment of malaria in pregnancy: at the crossroads of public health policy. Trop Med Int Health. 2011, 16: 774-785. 10.1111/j.1365-3156.2011.02765.x.CrossRefPubMed
5.
go back to reference Vallely A, Vallely L, Changalucha J, Greenwood B, Chandramohan D: Intermittent preventive treatment for malaria in pregnancy in Africa: what’s new, what’s needed?. Malar J. 2007, 6: 16-10.1186/1475-2875-6-16.PubMedCentralCrossRefPubMed Vallely A, Vallely L, Changalucha J, Greenwood B, Chandramohan D: Intermittent preventive treatment for malaria in pregnancy in Africa: what’s new, what’s needed?. Malar J. 2007, 6: 16-10.1186/1475-2875-6-16.PubMedCentralCrossRefPubMed
6.
go back to reference Harrington WE, Mutabingwa TK, Kabyemela E, Fried M, Duffy PE: Intermittent treatment to prevent pregnancy malaria does not confer benefit in an area of widespread drug resistance. Clin Infect Dis. 2011, 53: 224-230. 10.1093/cid/cir376.PubMedCentralCrossRefPubMed Harrington WE, Mutabingwa TK, Kabyemela E, Fried M, Duffy PE: Intermittent treatment to prevent pregnancy malaria does not confer benefit in an area of widespread drug resistance. Clin Infect Dis. 2011, 53: 224-230. 10.1093/cid/cir376.PubMedCentralCrossRefPubMed
7.
go back to reference O'Meara WP, Smith DL, McKenzie FE: Potential impact of intermittent preventive treatment (IPT) on spread of drug-resistant malaria. PLoS Med. 2006, 3: e141-10.1371/journal.pmed.0030141.CrossRefPubMed O'Meara WP, Smith DL, McKenzie FE: Potential impact of intermittent preventive treatment (IPT) on spread of drug-resistant malaria. PLoS Med. 2006, 3: e141-10.1371/journal.pmed.0030141.CrossRefPubMed
9.
go back to reference Kayentao K, Garner P, van Eijk AM, Naidoo I, Roper C, Mulokozi A, MacArthur JR, Luntamo M, Ashorn P, Doumbo OK, ter Kuile FO: Intermittent preventive therapy for malaria during pregnancy using 2 vs 3 or more doses of sulfadoxine-pyrimethamine and risk of low birth weight in Africa: systematic review and meta-analysis. JAMA. 2013, 309: 594-604. 10.1001/jama.2012.216231.CrossRefPubMed Kayentao K, Garner P, van Eijk AM, Naidoo I, Roper C, Mulokozi A, MacArthur JR, Luntamo M, Ashorn P, Doumbo OK, ter Kuile FO: Intermittent preventive therapy for malaria during pregnancy using 2 vs 3 or more doses of sulfadoxine-pyrimethamine and risk of low birth weight in Africa: systematic review and meta-analysis. JAMA. 2013, 309: 594-604. 10.1001/jama.2012.216231.CrossRefPubMed
10.
go back to reference Taylor SM, Antonia AL, Chaluluka E, Mwapasa V, Feng G, Molyneux ME, ter Kuile FO, Meshnick SR, Rogerson SJ: Antenatal receipt of sulfadoxine-pyrimethamine does not exacerbate pregnancy-associated malaria despite the expansion of drug-resistant Plasmodium falciparum: clinical outcomes from the QuEERPAM study. Clin Infect Dis. 2012, 55: 42-50. 10.1093/cid/cis301.PubMedCentralCrossRefPubMed Taylor SM, Antonia AL, Chaluluka E, Mwapasa V, Feng G, Molyneux ME, ter Kuile FO, Meshnick SR, Rogerson SJ: Antenatal receipt of sulfadoxine-pyrimethamine does not exacerbate pregnancy-associated malaria despite the expansion of drug-resistant Plasmodium falciparum: clinical outcomes from the QuEERPAM study. Clin Infect Dis. 2012, 55: 42-50. 10.1093/cid/cis301.PubMedCentralCrossRefPubMed
11.
go back to reference ter Kuile FO, van Eijk AM, Filler SJ: Effect of sulfadoxine-pyrimethamine resistance on the efficacy of intermittent preventive therapy for malaria control during pregnancy: a systematic review. JAMA. 2007, 297: 2603-2616. 10.1001/jama.297.23.2603.CrossRefPubMed ter Kuile FO, van Eijk AM, Filler SJ: Effect of sulfadoxine-pyrimethamine resistance on the efficacy of intermittent preventive therapy for malaria control during pregnancy: a systematic review. JAMA. 2007, 297: 2603-2616. 10.1001/jama.297.23.2603.CrossRefPubMed
12.
go back to reference Crawley J, Hill J, Yartey J, Robalo M, Serufilira A, Ba-Nguz A, Roman E, Palmer A, Asamoa K, Steketee R: From evidence to action? Challenges to policy change and programme delivery for malaria in pregnancy. Lancet Infect Dis. 2007, 7: 145-155. 10.1016/S1473-3099(07)70026-9.CrossRefPubMed Crawley J, Hill J, Yartey J, Robalo M, Serufilira A, Ba-Nguz A, Roman E, Palmer A, Asamoa K, Steketee R: From evidence to action? Challenges to policy change and programme delivery for malaria in pregnancy. Lancet Infect Dis. 2007, 7: 145-155. 10.1016/S1473-3099(07)70026-9.CrossRefPubMed
13.
go back to reference Mbonye AK, Magnussen P, Bygbjerg IB: Intermittent preventive treatment of malaria in pregnancy: the effect of new delivery approaches on access and compliance rates in Uganda. Trop Med Int Health. 2007, 12: 519-531. 10.1111/j.1365-3156.2007.01819.x.CrossRefPubMed Mbonye AK, Magnussen P, Bygbjerg IB: Intermittent preventive treatment of malaria in pregnancy: the effect of new delivery approaches on access and compliance rates in Uganda. Trop Med Int Health. 2007, 12: 519-531. 10.1111/j.1365-3156.2007.01819.x.CrossRefPubMed
14.
go back to reference Msyamboza KP, Savage EJ, Kazembe PN, Gies S, Kalanda G, D'Alessandro U, Brabin BJ: Community-based distribution of sulfadoxine-pyrimethamine for intermittent preventive treatment of malaria during pregnancy improved coverage but reduced antenatal attendance in southern Malawi. Trop Med Int Health. 2009, 14: 183-189. 10.1111/j.1365-3156.2008.02197.x.CrossRefPubMed Msyamboza KP, Savage EJ, Kazembe PN, Gies S, Kalanda G, D'Alessandro U, Brabin BJ: Community-based distribution of sulfadoxine-pyrimethamine for intermittent preventive treatment of malaria during pregnancy improved coverage but reduced antenatal attendance in southern Malawi. Trop Med Int Health. 2009, 14: 183-189. 10.1111/j.1365-3156.2008.02197.x.CrossRefPubMed
15.
go back to reference Akinleye SO, Falade CO, Ajayi IO: Knowledge and utilization of intermittent preventive treatment for malaria among pregnant women attending antenatal clinics in primary health care centers in rural southwest. Nigeria: a cross-sectional study. BMC Pregnancy Childbirth. 2009, 9: 28-10.1186/1471-2393-9-28.PubMedCentralCrossRefPubMed Akinleye SO, Falade CO, Ajayi IO: Knowledge and utilization of intermittent preventive treatment for malaria among pregnant women attending antenatal clinics in primary health care centers in rural southwest. Nigeria: a cross-sectional study. BMC Pregnancy Childbirth. 2009, 9: 28-10.1186/1471-2393-9-28.PubMedCentralCrossRefPubMed
16.
go back to reference Amoran OE, Ariba AA, Iyaniwura CA: Determinants of intermittent preventive treatment of malaria during pregnancy (IPTp) utilization in a rural town in Western Nigeria. Reprod Health. 2012, 9: 12-10.1186/1742-4755-9-12.PubMedCentralCrossRefPubMed Amoran OE, Ariba AA, Iyaniwura CA: Determinants of intermittent preventive treatment of malaria during pregnancy (IPTp) utilization in a rural town in Western Nigeria. Reprod Health. 2012, 9: 12-10.1186/1742-4755-9-12.PubMedCentralCrossRefPubMed
17.
go back to reference Hill J, Kazembe P: Reaching the Abuja target for intermittent preventive treatment of malaria in pregnancy in African women: a review of progress and operational challenges. Trop Med Int Health. 2006, 11: 409-418. 10.1111/j.1365-3156.2006.01585.x.CrossRefPubMed Hill J, Kazembe P: Reaching the Abuja target for intermittent preventive treatment of malaria in pregnancy in African women: a review of progress and operational challenges. Trop Med Int Health. 2006, 11: 409-418. 10.1111/j.1365-3156.2006.01585.x.CrossRefPubMed
18.
go back to reference Mubyazi GM, Bygbjerg IC, Magnussen P, Olsen O, Byskov J, Hansen KS, Bloch P: Prospects, achievements, challenges and opportunities for scaling-up malaria chemoprevention in pregnancy in Tanzania: the perspective of national level officers. Malar J. 2008, 7: 135-10.1186/1475-2875-7-135.PubMedCentralCrossRefPubMed Mubyazi GM, Bygbjerg IC, Magnussen P, Olsen O, Byskov J, Hansen KS, Bloch P: Prospects, achievements, challenges and opportunities for scaling-up malaria chemoprevention in pregnancy in Tanzania: the perspective of national level officers. Malar J. 2008, 7: 135-10.1186/1475-2875-7-135.PubMedCentralCrossRefPubMed
19.
go back to reference Sangare LR, Stergachis A, Brentlinger PE, Richardson BA, Staedke SG, Kiwuwa MS, Weiss NS: Determinants of use of intermittent preventive treatment of malaria in pregnancy: Jinja. Uganda. PLoS One. 2010, 5: e15066-10.1371/journal.pone.0015066.PubMedCentralCrossRefPubMed Sangare LR, Stergachis A, Brentlinger PE, Richardson BA, Staedke SG, Kiwuwa MS, Weiss NS: Determinants of use of intermittent preventive treatment of malaria in pregnancy: Jinja. Uganda. PLoS One. 2010, 5: e15066-10.1371/journal.pone.0015066.PubMedCentralCrossRefPubMed
20.
go back to reference Singh N, Squier C, Sivek C, Wagener M, Nguyen MH, Yu VL: Determinants of compliance with antiretroviral therapy in patients with human immunodeficiency virus: prospective assessment with implications for enhancing compliance. AIDS Care. 1996, 8: 261-269. 10.1080/09540129650125696.CrossRefPubMed Singh N, Squier C, Sivek C, Wagener M, Nguyen MH, Yu VL: Determinants of compliance with antiretroviral therapy in patients with human immunodeficiency virus: prospective assessment with implications for enhancing compliance. AIDS Care. 1996, 8: 261-269. 10.1080/09540129650125696.CrossRefPubMed
21.
go back to reference Vermeire E, Hearnshaw H, Van Royen P, Denekens J: Patient adherence to treatment: three decades of research. A comprehensive review. J Clin Pharm Ther. 2001, 26: 331-342. 10.1046/j.1365-2710.2001.00363.x.CrossRefPubMed Vermeire E, Hearnshaw H, Van Royen P, Denekens J: Patient adherence to treatment: three decades of research. A comprehensive review. J Clin Pharm Ther. 2001, 26: 331-342. 10.1046/j.1365-2710.2001.00363.x.CrossRefPubMed
23.
go back to reference Nordeng H, Ystrom E, Einarson A: Perception of risk regarding the use of medications and other exposures during pregnancy. Eur J Clin Pharmacol. 2010, 66: 207-214. 10.1007/s00228-009-0744-2.CrossRefPubMed Nordeng H, Ystrom E, Einarson A: Perception of risk regarding the use of medications and other exposures during pregnancy. Eur J Clin Pharmacol. 2010, 66: 207-214. 10.1007/s00228-009-0744-2.CrossRefPubMed
24.
go back to reference Mbonye AK, Neema S, Magnussen P: Perceptions on use of sulfadoxine-pyrimethamine in pregnancy and the policy implications for malaria control in Uganda. Health Policy. 2006, 77: 279-289. 10.1016/j.healthpol.2005.07.020.CrossRefPubMed Mbonye AK, Neema S, Magnussen P: Perceptions on use of sulfadoxine-pyrimethamine in pregnancy and the policy implications for malaria control in Uganda. Health Policy. 2006, 77: 279-289. 10.1016/j.healthpol.2005.07.020.CrossRefPubMed
25.
go back to reference Mubyazi G, Bloch P, Kamugisha M, Kitua A, Ijumba J: Intermittent preventive treatment of malaria during pregnancy: a qualitative study of knowledge, attitudes and practices of district health managers, antenatal care staff and pregnant women in Korogwe District. North-Eastern Tanzania. Malar J. 2005, 4: 31-10.1186/1475-2875-4-31.PubMedCentralCrossRefPubMed Mubyazi G, Bloch P, Kamugisha M, Kitua A, Ijumba J: Intermittent preventive treatment of malaria during pregnancy: a qualitative study of knowledge, attitudes and practices of district health managers, antenatal care staff and pregnant women in Korogwe District. North-Eastern Tanzania. Malar J. 2005, 4: 31-10.1186/1475-2875-4-31.PubMedCentralCrossRefPubMed
26.
go back to reference WHO Malaria Policy Advisory Committee and Global Malaria Programme: Malaria Policy Advisory Committee to the WHO: conclusions and recommendations of September 2012 meeting. Malar J. 2012, 11: 424-CrossRef WHO Malaria Policy Advisory Committee and Global Malaria Programme: Malaria Policy Advisory Committee to the WHO: conclusions and recommendations of September 2012 meeting. Malar J. 2012, 11: 424-CrossRef
27.
go back to reference National Malaria Control Program: Uganda National Malaria Control Policy 2011. 2011, Kampala: Ministry of Health National Malaria Control Program: Uganda National Malaria Control Policy 2011. 2011, Kampala: Ministry of Health
28.
go back to reference Sampling Techniques. Edited by: Cochran GW. 1963, New York: John Wiley and Sons, Inc., 2 Sampling Techniques. Edited by: Cochran GW. 1963, New York: John Wiley and Sons, Inc., 2
29.
go back to reference Ribera JM, Hausmann-Muela S, D'Alessandro U, Grietens KP: Malaria in pregnancy: what can the social sciences contribute?. PLoS Med. 2007, 4: e92-10.1371/journal.pmed.0040092.PubMedCentralCrossRefPubMed Ribera JM, Hausmann-Muela S, D'Alessandro U, Grietens KP: Malaria in pregnancy: what can the social sciences contribute?. PLoS Med. 2007, 4: e92-10.1371/journal.pmed.0040092.PubMedCentralCrossRefPubMed
32.
go back to reference Sun GW, Shook TL, Kay GL: Inappropriate use of bivariable analysis to screen risk factors for use in multivariable analysis. J Clin Epidemiol. 1996, 49: 907-916. 10.1016/0895-4356(96)00025-X.CrossRefPubMed Sun GW, Shook TL, Kay GL: Inappropriate use of bivariable analysis to screen risk factors for use in multivariable analysis. J Clin Epidemiol. 1996, 49: 907-916. 10.1016/0895-4356(96)00025-X.CrossRefPubMed
33.
go back to reference Kiwuwa MS, Mufubenga P: Use of antenatal care, maternity services, intermittent presumptive treatment and insecticide treated bed nets by pregnant women in Luwero district, Uganda. Malar J. 2008, 7: 44-10.1186/1475-2875-7-44.PubMedCentralCrossRefPubMed Kiwuwa MS, Mufubenga P: Use of antenatal care, maternity services, intermittent presumptive treatment and insecticide treated bed nets by pregnant women in Luwero district, Uganda. Malar J. 2008, 7: 44-10.1186/1475-2875-7-44.PubMedCentralCrossRefPubMed
34.
go back to reference Uganda Bureau of Statistics: Uganda Demographic and Health Survey 2011. 2012, Calverton, Maryland USA: ICF International Inc Uganda Bureau of Statistics: Uganda Demographic and Health Survey 2011. 2012, Calverton, Maryland USA: ICF International Inc
35.
go back to reference Kinney MV, Kerber KJ, Black RE, Cohen B, Nkumah F, Coovadia H, Nampala PM, Lawn JE, Axelson H, Bergh AM, Chopra M, Diab R, Friberg I, Odubanjo O, Walker N, Weissman E, Science in Action: Saving the lives of Africa’s Mothers, Newborns, and Children working group: Sub-Saharan Africa’s mothers, newborns and children: where and why do they die?. PLoS Med. 2010, 7: e1000294-10.1371/journal.pmed.1000294.PubMedCentralCrossRefPubMed Kinney MV, Kerber KJ, Black RE, Cohen B, Nkumah F, Coovadia H, Nampala PM, Lawn JE, Axelson H, Bergh AM, Chopra M, Diab R, Friberg I, Odubanjo O, Walker N, Weissman E, Science in Action: Saving the lives of Africa’s Mothers, Newborns, and Children working group: Sub-Saharan Africa’s mothers, newborns and children: where and why do they die?. PLoS Med. 2010, 7: e1000294-10.1371/journal.pmed.1000294.PubMedCentralCrossRefPubMed
36.
go back to reference Pell C, Menaca A, Were F, Afrah NA, Chatio S, Taylor LM, Hamel MJ, Hodgson A, Tagbor H, Kalilandi L, Ouma P, Pool R: Factors affecting antenatal care attendance: results from qualitative studies in Ghana, Kanya and Malawi. PLoS One. 2013, 8: e53747-10.1371/journal.pone.0053747.PubMedCentralCrossRefPubMed Pell C, Menaca A, Were F, Afrah NA, Chatio S, Taylor LM, Hamel MJ, Hodgson A, Tagbor H, Kalilandi L, Ouma P, Pool R: Factors affecting antenatal care attendance: results from qualitative studies in Ghana, Kanya and Malawi. PLoS One. 2013, 8: e53747-10.1371/journal.pone.0053747.PubMedCentralCrossRefPubMed
37.
go back to reference Simkhada B, Teijlingen ER, Porter M, Simkhada P: Factors affecting the utilization of antenatal care in developing countries: systematic review of the literature. J Adv Nurs. 2008, 61: 244-260. 10.1111/j.1365-2648.2007.04532.x.CrossRefPubMed Simkhada B, Teijlingen ER, Porter M, Simkhada P: Factors affecting the utilization of antenatal care in developing countries: systematic review of the literature. J Adv Nurs. 2008, 61: 244-260. 10.1111/j.1365-2648.2007.04532.x.CrossRefPubMed
38.
go back to reference Anders K, Marchant T, Chambo P, Mapunda P, Reyburn H: Timing of intermittent preventive treatment for malaria during pregnancy and implications for current policy on early uptake in north-east Tanzania. Malar J. 2008, 7: 79-10.1186/1475-2875-7-79.PubMedCentralCrossRefPubMed Anders K, Marchant T, Chambo P, Mapunda P, Reyburn H: Timing of intermittent preventive treatment for malaria during pregnancy and implications for current policy on early uptake in north-east Tanzania. Malar J. 2008, 7: 79-10.1186/1475-2875-7-79.PubMedCentralCrossRefPubMed
39.
go back to reference Kisuule I, Kaye DK, Najjuka F, Ssematimba SK, Arinda A, Nakitende G, Otim L: Timing and reasons for coming late for the first antenatal care visit by pregnant women at Mulago hospital, Kampala Uganda. BMC Pregnancy Childbirth. 2013, 13: 121-10.1186/1471-2393-13-121.PubMedCentralCrossRefPubMed Kisuule I, Kaye DK, Najjuka F, Ssematimba SK, Arinda A, Nakitende G, Otim L: Timing and reasons for coming late for the first antenatal care visit by pregnant women at Mulago hospital, Kampala Uganda. BMC Pregnancy Childbirth. 2013, 13: 121-10.1186/1471-2393-13-121.PubMedCentralCrossRefPubMed
40.
go back to reference Sangare LR, Weiss NS, Brentlinger PE, Richardson BA, Staedke SG, Kiwuwa MS, Stergachis A: Patterns of anti-malarial drug treatment among pregnant women in Uganda. Malar J. 2011, 10: 152-10.1186/1475-2875-10-152.PubMedCentralCrossRefPubMed Sangare LR, Weiss NS, Brentlinger PE, Richardson BA, Staedke SG, Kiwuwa MS, Stergachis A: Patterns of anti-malarial drug treatment among pregnant women in Uganda. Malar J. 2011, 10: 152-10.1186/1475-2875-10-152.PubMedCentralCrossRefPubMed
41.
go back to reference Mbonye A, Birungi J, Yanow S, Magnussen P: Prescription patterns and drug use among pregnant women with febrile illnesses in Uganda: a survey in out-patient clinics. BMC Infect Dis. 2013, 13: 237-242. 10.1186/1471-2334-13-237.PubMedCentralCrossRefPubMed Mbonye A, Birungi J, Yanow S, Magnussen P: Prescription patterns and drug use among pregnant women with febrile illnesses in Uganda: a survey in out-patient clinics. BMC Infect Dis. 2013, 13: 237-242. 10.1186/1471-2334-13-237.PubMedCentralCrossRefPubMed
42.
go back to reference Peters PJ, Thigpen MC, Parise ME, Newman RD: Safety and toxicity of sulfadoxine/pyrimethamine: implications for malaria prevention in pregnancy using intermittent preventive treatment. Drug Saf. 2007, 30: 481-501. 10.2165/00002018-200730060-00003.CrossRefPubMed Peters PJ, Thigpen MC, Parise ME, Newman RD: Safety and toxicity of sulfadoxine/pyrimethamine: implications for malaria prevention in pregnancy using intermittent preventive treatment. Drug Saf. 2007, 30: 481-501. 10.2165/00002018-200730060-00003.CrossRefPubMed
Metadata
Title
Intermittent use of sulphadoxine-pyrimethamine for malaria prevention: a cross-sectional study of knowledge and practices among Ugandan women attending an urban antenatal clinic
Authors
Charles O Odongo
Ronald K Bisaso
Josaphat Byamugisha
Celestino Obua
Publication date
01-12-2014
Publisher
BioMed Central
Published in
Malaria Journal / Issue 1/2014
Electronic ISSN: 1475-2875
DOI
https://doi.org/10.1186/1475-2875-13-399

Other articles of this Issue 1/2014

Malaria Journal 1/2014 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.